Characterization of intrinsic factors that determine GABAA receptor (GABAR) inhibitory postsynaptic current (IPSC) shape and the magnitude of extrasynaptic tonic inhibitory current are fundamental issues in inhibitory synaptic physiology. Alterations in phasic, synaptic (? subunit-containing) and tonic, extrasynaptic (d subunit-containing) inhibition due to mutations of ? and d subunits have been shown to underlie several types of genetic generalized epilepsies. To understand the bases for genetic epilepsies involving GABAR gene mutations, it is necessary to understand the functional properties of GABARs that mediate phasic and tonic inhibition. The goals of this proposal are to determine the GABAR functional properties and structural domains that regulate phasic and tonic GABAR currents and to characterize the functional deficits in phasic and tonic GABAerqic inhibition produced by ?2S and d subunit epilepsy mutations. The hypotheses to be tested are that: a) The structural determinants of aa? and aad GABAR gating modes involve non-channel (non-M2) structures including M2/M3, M1 and the N-terminus loop 2. b) Fast/intermediate and slow/ultraslow desensitization of GABAR currents are determined by distinct, structurally separate domains, c) The ?2L(R42Q) mutation reduces """"""""synaptic"""""""" a1a2?2L(R42Q) current by reducing cell surface expression, d) The ?2L(K289M) mutation reduces """"""""synaptic"""""""" a1a2?2L (K289M) current by destabilizing channel open states, e) The ?2L(Q351X) mutation reduces """"""""synaptic"""""""" a1a2?2L (Q351X) current by impairing receptor assembly and decreasing surface expression, f) The d(mutant) reduces """"""""tonic"""""""" a4a2d(mutant) current by destabilizing channel open states.
The specific aims are to determine: a) The structural determinants of aa? and aad GABAR gating modes, b) The structural determinants of desensitization of aa? and aad GABARs. c) The basis for the reduced """"""""synaptic"""""""" current in heterozygous a1a2?2L(R42Q) GABARs. d) The basis for the reduced """"""""synaptic"""""""" current in heterozygous a1a2?2L(K289M) GABARs. e) The basis for the reduced """"""""synaptic"""""""" current in heterozygous a1a2?2L(Q351X) GABARs. f) The basis for the reduced """"""""synaptic"""""""" current in heterozygous a4a2d(mutant) GABARs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
3R01NS033300-12S1
Application #
7213722
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Stewart, Randall R
Project Start
1995-05-01
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
12
Fiscal Year
2006
Total Cost
$119,826
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Neurology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Lagrange, Andre H; Hu, NingNing; Macdonald, Robert L (2018) GABA beyond the synapse: defining the subtype-specific pharmacodynamics of non-synaptic GABAA receptors. J Physiol 596:4475-4495
Wang, Chen-Hung; Hernandez, Ciria C; Wu, Junyi et al. (2018) A Missense Mutation A384P Associated with Human Hyperekplexia Reveals a Desensitization Site of Glycine Receptors. J Neurosci 38:2818-2831
Hernandez, Ciria C; Kong, Weijing; Hu, Ningning et al. (2017) Altered Channel Conductance States and Gating of GABAA Receptors by a Pore Mutation Linked to Dravet Syndrome. eNeuro 4:
Ishii, Atsushi; Kang, Jing-Qiong; Schornak, Cara C et al. (2017) A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy. J Med Genet 54:202-211
Shen, Dingding; Hernandez, Ciria C; Shen, Wangzhen et al. (2017) De novo GABRG2 mutations associated with epileptic encephalopathies. Brain 140:49-67
Hernandez, Ciria C; Klassen, Tara L; Jackson, Laurel G et al. (2016) Deleterious Rare Variants Reveal Risk for Loss of GABAA Receptor Function in Patients with Genetic Epilepsy and in the General Population. PLoS One 11:e0162883
Botzolakis, Emmanuel J; Gurba, Katharine N; Lagrange, Andre H et al. (2016) Comparison of ?-Aminobutyric Acid, Type A (GABAA), Receptor ??? and ??? Expression Using Flow Cytometry and Electrophysiology: EVIDENCE FOR ALTERNATIVE SUBUNIT STOICHIOMETRIES AND ARRANGEMENTS. J Biol Chem 291:20440-61
Janve, Vaishali S; Hernandez, Ciria C; Verdier, Kelienne M et al. (2016) Epileptic encephalopathy de novo GABRB mutations impair ?-aminobutyric acid type A receptor function. Ann Neurol 79:806-825
Kang, Jing-Qiong; Macdonald, Robert L (2016) Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome. JAMA Neurol 73:1009-16
Kang, Jing-Qiong; Shen, Wangzhen; Zhou, Chengwen et al. (2015) The human epilepsy mutation GABRG2(Q390X) causes chronic subunit accumulation and neurodegeneration. Nat Neurosci 18:988-96

Showing the most recent 10 out of 72 publications